Enrolling by invitationPhase 2NCT06843811
Sirolimus for Leigh Syndrome
Studying Leigh syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Matthew Demczko
- Principal Investigator
- Matthew Demczko, MDChildren's Hospital of Philadelphia
- Intervention
- Sirolimus(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 55 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06843811 on ClinicalTrials.govOther trials for Leigh syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06967831Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural CellsCharite University, Berlin, Germany
- RECRUITINGNANCT03137355The International Registry for Leigh SyndromeThe University of Texas Health Science Center, Houston
- RECRUITINGNCT01780168The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of MetabolismNational Human Genome Research Institute (NHGRI)